Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New study suggests that having COVID-19 increases a person’s risk of developing psychiatric disorders, and that having a psychiatric disorder increases the chance of getting COVID-19. The study, published in The Lancet Psychiatry, used the TriNetX electronic health records of 69 million people in the USA including over 62,000 cases of COVID-19.

Facemask and open lock with lockdown written on it and a world map etched into it.

Researchers at the University of Oxford, Department of Psychiatry and NIHR Oxford Health Biomedical Research Centre, report the first large-scale evidence that COVID-19 survivors are at an increased risk of psychiatric disorders. 

  • Almost 1 in 5 people diagnosed with COVID-19 receive a psychiatric diagnosis within the next 3 months
  • 1 in 4 of these people had not had a psychiatric diagnosis before COVID-19
  • Patients with existing psychiatric disorders might be more likely to get COVID-19

In the 3 months following testing positive for COVID-19, 1 in 5 survivors were found to get a diagnosis of anxiety, depression, or insomnia, for the first time. This is about twice as likely as for other groups of patients over the same period. A diagnosis of dementia may also be commoner. COVID-19 was also associated with more new psychiatric diagnoses in people who already had a history of psychiatric problems. Overall, almost 20 per cent of people received a psychiatric diagnosis within 90 days of getting COVID-19. 

The full story is available on the Department of Psychiatry website

 

 

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.